Sanjay Mistry

Janssen

Sanjay brings a decade of experience from venture capital, academia, biotech, medical device, and pharmaceutical R&D to his work. In his role at Janssen (a Johnson & Johnson subsidiary), Sanjay is responsible for business operations, including the new internal venture selection process, portfolio planning, and external investor development in partnership with Johnson & Johnson Development Corporation and Business Development. He also leads internal ventures, focused on the discovery and development of novel small molecule drugs based on natural product starting points.

Previously, Sanjay was at Quaker Partners, involved in all aspects of the investment process and focused on biopharmaceuticals, diagnostics, medical devices, and healthcare services. He was a board observer at BioLeap, Corridor Pharma, Tarsa Therapeutics, and RainDance Technologies.

Prior to joining Quaker in 2008, Sanjay had an earlier tenure at Johnson & Johnson. He was Assistant Director of Business Development for the Stem Cell Internal Ventures Program at Centocor, a subsidiary. He held responsibilities for therapeutic area strategy planning and implementation and managed life science alliances around the world. As a Principal Scientist he successfully led pre-clinical development for an ophthalmology indication from discovery through IND into clinical trials. Prior to joining the internal ventures program, Sanjay created a neural tissue engineering program for the Center for Biomaterials and Advanced Technologies at Ethicon, another subsidiary.

Prior to J&J, Sanjay was a development scientist for biotech startup MorphoGen Pharmaceuticals, leading pre-clinical development. Earlier, he held postdoctoral fellowships at the Scripps Research Institute and at the University of Pittsburgh Medical School. He has therapeutic area expertise in cardiovascular, diabetes and neurological diseases.

Education, Personal, and Fellowship

Sanjay earned his PhD in Biochemical Pharmacology and MSc in Clinical Pharmacology from the University of Aberdeen, Scotland and his BSc in Applied Biology from Nottingham Trent University, UK. He has 3 issued patents, 23 pending applications and 19 peer reviewed publications. Sanjay enjoys sports, cooking, and travelling.

Sanjay is a member of Class 14 and served his fellowship at Quaker BioVentures under mentor Adele Oliva, a member of Fellows Class 2.